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Abstract
Background: Thymosin beta-4 (Tb4) is a ubiquitous protein with many properties relating to cell proliferation and
differentiation that promotes wound healing and modulates inflammatory mediators. The mechanism by which Tb4
modulates cardiac protection under oxidative stress is not known. The purpose of this study is to dissect the
cardioprotective mechanism of Tb4 on H2O2 induced cardiac damage.
Methods: Rat neonatal cardiomyocytes with or without Tb4 pretreatment were exposed to H2O2 and expression of
antioxidant, apoptotic, and anti-inflammatory genes was evaluated by quantitative real-time PCR and western blotting. ROS
levels were estimated by DCF-DA using fluorescent microscopy and fluorimetry. Selected antioxidant, anti-inflammatory and
antiapoptotic genes were silenced by siRNA transfections in neonatal cardiomyocytes and effect of Tb4 on H2O2-induced
cardiac damage was evaluated.
Results: Pre-treatment of Tb4 resulted in reduction of the intracellular ROS levels induced by H2O2 in cardiomyocytes. Tb4
pretreatment also resulted in an increase in the expression of antiapoptotic proteins and reduction of Bax/BCl2 ratio in the
cardiomyocytes. Pretreatment with Tb4 resulted in stimulating the expression of antioxidant enzymes copper/zinc SOD and
catalase in cardiomyocytes at both transcription and translation levels. Tb4 treatment resulted in the increased expression of
anti-apoptotic and anti-inflammatory genes. Silencing of Cu/Zn SOD and catalase gene resulted in apoptotic cell death in
the cardiomyocytes which was prevented by treatment with Tb4.
Conclusion: This is the first report that demonstrates the effect of Tb4 on cardiomyocytes and its capability to selectively
upregulate anti-oxidative enzymes, anti-inflammatory genes, and antiapoptotic enzymes in the neonatal cardiomyocytes
thus preventing cell death thereby protecting the myocardium. Tb4 treatment resulted in decreased oxidative stress and
inflammation in the myocardium under oxidative stress.
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Introduction
Adverse cardiac remodeling is a detrimental process account-
able for the development of various cardiac diseases including
myocardial infarction, cardiac hypertrophy and heart failure.
Although the mechanisms underlying the cardiac remodeling are
multi-factorial, current evidences suggest that oxidative stress plays
a critical role in the process. Oxidative stress is defined as an
imbalance in antioxidant defense mechanism that elicits the
production of reactive oxygen species (ROS) [1–4]. ROS are
primarily characterized as oxygen based free chemical particles, if
present in excess, causes contractile dysfunction and structural
damage in the myocardium [5]. Therefore the balance between
ROS production and removal of excess ROS are essential in
maintaining the redox state and, homeostasis balance in the cell
[6]. At the subcellular level, increased ROS levels can cause
damage to nucleic acids and proteins leading to programmed cell
death or apoptosis [7–9]. Thus, ROS mediated oxidative damage
in cardiomyocytes is responsible for structural integrity of the
myocardium.
It has been reported that increase in the levels of oxidative stress
in the failing heart is primarily due to the functional uncoupling of
the respiratory chain caused by inactivation of complex I in the
mitochondria and considered to be a good source for ROS
production [10,11]. Another source would consider is the
impaired antioxidant capacity that include superoxide dismutase
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(SOD), glutathione peroxidase (GSH-Px), and catalase (CAT) and
considered as such as the first line of cellular defense against
oxidative injury [12]. Accumulating evidences indicate that
cardiac overexpression of Mn-SOD or CAT protects the heart
from ischemic insult or myocardial infarction [13,14].
Oxidative stress triggers pro-inflammatory signaling pathways
that activate nuclear factor kappa B (NF-kB) and AP-1 transcrip-
tion factors [15]. Previously, we and others have shown that NF-
kB activation is associated with cardiac dysfunction, ventricular
hypertrophy, and maladaptive cardiac growth [16–20]. The
biochemical nexus between oxidative stress and inflammation
represent an integral part in the pathophysiology of myocardial
damage.
Thus, it is evident from our literature that oxidative damage
remains a great challenge to promote significant myocardial
damage and, numerous efforts have been made in the search of
strategies to protect the heart against oxidative damage. In search
of an ideal cardio-protective agent, Thymosin b4 (Tb4) emerged
as powerful candidate.
Tb4, a G-actin sequestering molecule is primarily implicated in
reorganizing actin cytoskeleton that needed for cell mobility [21].
Moreover, Tb4 is present in all cells and body fluids and, has
diverse biological function that includes tissue development, repair
and pathology [21,22]. Importantly, Tb4 contributes a significant
cardiac repair mechanism by activating integrin link kinase [23–
25] and, has further shown to promote cardiac regeneration,
epicardial cell migration and neovascularization [26,27]. Our
previous study demonstrated that treatment of Tb4 restored the
adverse cardiac remodeling (due to ischemic insult) by reducing
inflammation, fibrosis and, activating ILK, PINCH and a-Parvin
[27]. In the case of oxidative stress, Tb4 has been shown to protect
the cells by enhancing antioxidant enzymes and reducing caspase
9 activation in human corneal epithelial cells [28–30]. Under this
setting, we recently have shown in cardiac fibroblast that Tb4 has
the target for SOD and catalase and thereby protect the cell from
oxidative stress [31]. But the exact mechanism by which Tb4
functions in the myocardium under oxidative stress and its effects
on the cardiac myocytes is largely unknown.
The present study elucidates the protective mechanism of Tb4
under oxidative stress using rat neonatal cardiac myocytes. We
hypothesize that Tb4 protect myocytes under oxidative stress by
modulating antioxidant enzymes, apoptotic genes and pro-
inflammatory genes. As for the limitation of our study, we used
neonatal cardiomyocytes to study the protective effect of Tb4
under oxidative stress conditions that may not mimic the changes
in clinical conditions, and thus results using cultured cardiomy-
ocytes should be interpreted carefully. An advantage of neonatal
cardiomyocytes is the easy procedure for their isolation in contrast
to adult cardiomyocytes, which are very sensitive to the
concentration of Ca2+ in the medium. Moreover, the phenotype
of cultured neonatal cardiomyocytes is very stable and their
contractile profile very closely mimicking the adult cardiomyo-
cytes. Experiments in isolated neonatal cardiomyocytes have
generally reproduced the results on adult cardiomyocytes with a
wide variety of interventions exploring the cellular and molecular
mechanisms in oxidative stress.
Materials and Methods
Reagents
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), hydrogen peroxide (H2O2) (Sigma), dimethyl sulfoxide
(DMSO), dihydroethidium (DHE), dichlorofluorescein diacetate
(DCF-DA), diaminofluorescein 2-diacetate (DAF-2DA), 3,39-
dihexyloxacarbocyanine iodide (DiOC6), and chloromethyl-X-
rosamine (MitoTracker red) were purchased from Molecular
Probes, Invitrogen, USA. Antibodies for Mn-SOD, Cu/Zn-SOD,
Catalase, GAPDH, Bax, Bcl2, caspase-3 were purchased from Cell
Signaling Technologies, USA Santa Cruz Biotechnologies (USA),
Immuno-Rockland (USA). Protease inhibitor cocktail tablets were
purchased from Roche GmbH, Germany. Dulbecco’s Modified
Eagle Medium (DMEM), non-essential amino acid cocktail,
insulin, transferrin and selenium (ITS), and fetal Bovine Serum
(FBS) were purchased from GIBCO, Invitrogen (USA). Thymosin
b4 was supplied by RegeneRx Pharmaceutical.
Cell culture and treatment
Primary cultures of cardiac myocytes were prepared from
ventricles of 1–3-day-old Wistar rats as described previously [32].
In brief, cardiomyocytes were plated at a field density of 2.56104
cells per cm2 on coverslips, 6-well plates, 60-mm culture dishes, or
100-mm dishes as required with DMEM containing 10% FBS and
supplemented with insulin, transferrin and selenium and bromo-
deoxy-uridine. After 24 h, cells were serum deprived overnight
before stimulation. A standardized dose of 100 mM H2O2 was
used to induce oxidative stress in the in vitro system. To study the
protective effects of Tb4, cells were pretreated with Tb4 2 hours
prior to H2O2 challenge. The final concentration of Tb4 used in
this study was 1 mg/ml which was based on previous reports
[28,32].
Detection of the cell viability
Cell viability of cardiac myocytes was measured quantitatively
using MTT as described previously [31]. The absorbance was
measured at 570 nm using a microplate reader (Molecular
Devices, SpectraMax 250). The effect of Tb4 was assessed on
the H2O2 treated myocyte and the cytotoxicity curve was made
and, expressed as percentage cell viability compared to control.
Measurement of intracellular ROS levels
For measuring the levels of intracellular ROS, cardiac myocytes
after treatments were incubated with 50 mM 29,79-dichlorodihy-
drofluorescein diacetate (H2DCFH-DA, Molecular Probes, Eu-
gene, OR) at 37uC in the dark for 30 min as described previously
[31].
Confocal microscopy
For measuring the levels of intracellular ROS, cells were seeded
on coverslips in 6-well plates and after treatments were incubated
with 50 mM 29,79-dichlorodihydrofluorescein diacetate (H2DCFH-
DA, Molecular Probes, Eugene, OR) at 37uC in the dark for
30 min as previously described [31]. Cells were then fixed and
mounted on glass slides and observed under confocal laser
scanning microscope (Fluoview FV1000) fitted with a 488 nm
argon ion laser. Images were acquired using the F10-ASW 1.5
Fluoview software.
Western blot analysis
Cardiac myocytes were treated with or without Tb4 for 2 h
before stimulated with 100 mM of H2O2. The cell lysate
preparation, western blot analysis and image quantification were
performed as described previously [31].
RNA isolation and quantitative RT-PCR (q RT-PCR)
analysis
Cardiomyocytes were treated with or without Tb4 for 2 h
followed by stimulation with H2O2 (100 mM) for up to 24 h. The
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preparation of RNA, 1st strand cDNA synthesis and q RT-PCR
was performed as described previously [31]. Analysis of relative
gene expression was done by evaluating the real-time quantitative
PCR data by 2(2DDCt) method as described previously by others
[33,34]. GAPDH or 18S was used as housekeeping gene.
RNA interference and siRNA transfection
The gene silencing experiment using small interfering (si) RNA
of Cu/Zn-SOD and Bcl2 was performed using predesigned
double-stranded siRNA of the above from Sigma Life Science,
Saint Louis MO, USA as described previously [31]. A scramble
siRNA was used for negative control was also obtained from
Sigma. In brief, cells were then transfected with 200 pmol of the
siRNAs for Cu/Zn-SOD and Bcl2 or negative control siRNA
using N-TERTM nanoparticle siRNA transfection system (Sigma)
in accordance with the manufacturer’s protocol. After 24 h of
transfection, cells were treated and harvested to determine the
transfection efficiency and effect of Tb4 treatment on H2O2
treatment in the transfected cells.
TUNEL staining
Quantification of TUNEL staining was done to study the extent
of apoptotic cell death on transfected fibroblasts by in situ cell death
detection kit (Roche Applied Science, Indianapolis, IN) as
described previously [31].
Statistical analysis
All experiments were performed at least three times for each
determination. Data are expressed as means6 standard error (SE)
and were analyzed using one-way analysis of variance and
secondary analysis for significance with Tukey–Kramer post tests
using Prism 5.0 GraphPad software (GraphPad, San Diego, CA,
USA). A p value less than 0.05 was considered statistically
significant.
Results
Tb4 protects cardiomyocytes cells against H2O2-induced
cell death
The viability of cardiomyocytes was determined by MTT assay.
Cardiomyocytes were treated with increasing doses of H2O2 and,
cell viability was determined over a period of 24 hours. Our data
showed that the 50% lethal dose (LD50) of H2O2 was between 150
and 250 mM (Figure 1A). Pretreatment with Tb4 (1 mg/mL)
prevented the myocyte cell death by 23.4% (p,0.05), compared to
the H2O2-treated group indicating a protective role of Tb4 in
cardiomyocytes. The optimal sub-lethal concentration of H2O2
was determined and 100 mM H2O2 was used for the entire study.
Tb4 protects cardiomyocytes in H2O2-induced oxidative
stress
Intracellular ROS levels in myocytes for 12 and 24 h post-H2O2
(100 mM) treatment were subsequently measured by fluorimetry
and confocal microscopy analyses. There was an increase in ROS
Figure 1. Effect of Tb4 on cell viability in H2O2-treated
cardiomyocytes. (A) The MTT assay was performed with increasing
H2O2 concentration (1 to 250 mM) in presence (dotted lines) and
absence (solid lines) of Tb4 (1 mg/mL). Data represent means 6 SEM of
3 individual experiments. (B). Effect of Tb4 on generation of ROS in
cardiomyocytes treated with H2O2 by fluorimetry. The graph represents
the percentage of fluorescence positive cardiomyocytes upon staining
with DCF-DA. Data represent the mean 6 SE of at least three separate
experiments. * means p,0.05 compared to the controls and #
represents p,0.05 compared to the respective H2O2 treated group (C)
Representative confocal laser scanning microscopy images of cardio-
myocytes stained with DCF-DA showing the effect of Tb4 on
intracellular ROS upon treatment with H2O2. (D) Representative
confocal laser scanning microscopy images of cells stained with DHE
Red showing the effect of Tb4 on generation of superoxide radicals
upon treatment with H2O2 in cardiomyocytes. (E). Representative
confocal laser scanning microscopy images of cells stained with DAF-
2DA showing the effect of Tb4 on generation of nitric oxide upon
treatment with H2O2 in cardiomyocytes. (F). Representative confocal
laser scanning microscopy images of cells stained with Mitotracker Red
showing the effect of Tb4 on loss of mitochondrial membrane potential
upon treatment with H2O2 in cardiomyocytes.
doi:10.1371/journal.pone.0042586.g001
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activity as indicated by increased fluorescence intensity of DCF-
DA in the cardiomyocytes after H2O2 treatment (Figure 1B and 1
C). The fluorescence intensity of DCF-DA (indicative of oxidative
burst) increased by 2.8-fold at 12 h (p,0.01) and 10.8-fold at 24 h
(p,0.001), respectively, in the H2O2-treated group, compared to
the untreated cardiomyocytes. Pretreatment with Tb4 resulted in a
5.3% decrease at 12 h (n.s.) and 54.5% decrease at 24 h (p,0.01),
respectively, compared to the H2O2-treated cells (Figure 1B and
C) suggesting Tb4 rescues cardiomyocytes from oxidative stress at
later time-point. The quantifications of image intensities have been
tabulated in Table 1.
Tb4 reduces the formation of superoxide radicals and
nitric oxide in H2O2-induced oxidative stress in
cardiomyocytes
H2O2 treatment induces a cascade of biochemical reaction in
the cell leading to generation and accumulation of a variety of free
radicals in the cells. We estimated the levels of superoxide and
nitric oxide by using confocal microscopy. Our data revealed that
there was an increase in the fluorescence intensity of DHE and
DAF-2DA in H2O2 treated cells, an indicator of O2
.2 and NO
radicals, compared to unstimulated cells (Figure 1D and 1E). This
increase in the fluorescence intensity of DHE and DAF-2A was
significantly prevented by Tb4 pretreatment. The quantifications
of image intensities have been tabulated in Table 1.
Tb4 treatment protects mitochondrial membrane
potential (DYm) in oxide in H2O2-induced oxidative
stress in cardiomyocytes
Oxidative stress is known to elicit depolarization of mitochon-
drial membrane potential. We evaluated the effect of Tb4 on the
mitochondrial membrane potential in H2O2 stimulated cardio-
myocytes using MitoTracker Red by confocal microscopy. Our
data revealed that there was loss of mitochondrial membrane
potential as indicated by a decrease in the fluorescence intensity of
MitoTracker Red H2O2 stimulated cell. Tb4 treatment signifi-
cantly restored the phenomenon (Figure 1F). The quantifications
of image intensities have been tabulated in Table 1.
Tb4 upregulates antioxidant genes in cardiac myocytes
under oxidative stress
Since, oxidative stress alters the expression of antioxidant
enzymes; we examined the mRNA expression of antioxidant
genes, Mn-SOD, Cu/Zn-SOD and catalase in cardiomyocytes by
q RT-PCR. In cardiomyocytes, the mRNA expression of Mn-
SOD showed an initial increase and then a subsequent decline
under H2O2 treatment. H2O2 treatment resulted in an increase in
the Mn-SOD mRNA expression in 12 h by 1.8-fold and in 24 h
by 1.7-fold, respectively (p,0.05), compared to the untreated cells.
Tb4 treatment did not significantly change the expression of Mn-
SOD. Tb4 pretreatment resulted in 1.07-fold (p = ns) and 1.04-
fold (p = ns) decline in the mRNA expression of Mn-SOD at 12 h
and 24 h, respectively, compared to H2O2-treated cells
(Figure 2A). Neonatal cardiomyocytes treated with H2O2 showed
a decline in the mRNA expression of Cu/Zn-SOD by 1.85-fold at
12 h (p,0.05) and 3.3-fold at 24 h (p,0.05), respectively,
compared to the control. Compared to the H2O2-treated cells,
pretreatment with Tb4 upregulated the mRNA expression of Cu/
Zn-SOD showing a 1.5-fold (p,0.001) and 2.9-fold (p,0.001)
increase at 12 h and 24 h, respectively, suggesting that Tb4
treatment reverts the Cu/Zn-SOD to normal (Figure 2B). The
expression of antioxidant catalase which is a primary scavenger of
H2O2 was also evaluated. The expression of catalase showed 2.12-
fold and 2.77-fold (p,0.05) decline at 12 h and 24 h, respectively.
Pretreatment with Tb4 increased the mRNA expression of
catalase by 1.4-fold (p,0.05) and 4.1-fold (p,0.05) at 12 h and
24 h, respectively, compared to H2O2-treated cells (Figure 3C)
indicating that Tb4 treatment prevented the depletion of
antioxidant enzyme genes under oxidative stress (Figure 2C).
To evaluate the status of these antioxidant enzymes at protein
levels, western blots were performed. Our data showed that the
levels of Mn-SOD increased upon H2O2 challenge but did not
change significantly upon treatment with Tb4 The expression of
Cu/Zn-SOD in H2O2-treated cells was reduced by 1.38-fold
(p,0.05) and 1.5-fold (p,0.05) at 12 h and 24 h, respectively,
compared to the untreated cells. The level of Cu/Zn-SOD was
restored in Tb4 treatment and showed a 2.0-fold (p,0.05) and
2.2-fold (p,0.05) increase at 12 h, and 24 h, respectively,
compared to H2O2-treated cells. Similar changes were noted in
the expression of antioxidant catalase, Tb4 treatment per se
increased the expression of catalase in the control cells by1.2-fold.
There was 1.2-fold (p,0.05) and 1.85-fold (p,0.05) decrease in
catalase treated with H2O2 at 12 h and 24 h, respectively,
compared to the untreated cells. Pretreatment with Tb4 resulted
in an increase in the expression of catalase by 1.3-fold (p,0.05),
and 1.8-fold (p,0.05) at 12 h and 24 h, respectively, compared to
H2O2-treated cells. This indicates that Tb4 preferentially
upregulates the expression of Cu/Zn-SOD and catalase under
oxidative stress (Figure 2D & E). The normalized quantification of
Mn-SOD, Cu/Zn-SOD and catalase by western blotting is shown
in the Figure 3E.
Tb4 protects cardiomyocytes from oxidative stress by
increasing anti-apoptotic gene and reducing pro-
apoptotic genes
Since oxidative stress leads to apoptotic cell death in cardio-
myocytes, we evaluated the expression of pro- and anti-apoptotic
genes. We determine the gene expression of Caspase-3, Bax and
Bcl2 in H2O2 treated cells in the presence and absence of Tb4.
Under oxidative stress, there was a 6.6-fold (p,0.05), and 7.2-fold
(p,0.05) increase in the mRNA expression of caspase3 in 12 h
and 24 h, respectively compared to control. Tb4 treatment
resulted in 1.56-fold (p,0.05) and 1.58-fold (p,0.05) decrease
in the mRNA expression of caspase3 at 12 h and 24 h treatment,
respectively, compared to the H2O2-treated cardiomyocytes
(Fig. 3A). Compared to the controls, H2O2 treatment resulted in
an increase in the mRNA expression of Bax by 2.4-fold and 2.4
fold (p,0.05) at 12 h and 24 h, respectively (Figure 3 B). Tb4
treatment reduced the increased Bax expression by 1.13-fold
(p = n.s) and 1.2-fold (p,0.05) at 12 h and 24 h, respectively,
Table 1. Image intensities (Arbitrary Units) showing the
fluorescence intensities in cardiomyocytes upon staining with
DCF-DA, DHE, DAF-2DA and MitoTracker Red.
S. No. Staining Control Tb4 H2O2 H2O2+Tb4
1 DCF-DA 339629 213643* 792653* 273632#
2 DHE 592671 602668 904650* 711662#
3 DAF-2DA 414639 184637* 1311692* 375629#
4 MitoTracker Red 361638 370647 237629* 349624#
Data acquired from at least 15 fields taken from 3–4 different confocal images
of the same treatment group and were quantified by using ImageJ Software.
*denotes p,0.05 compared to controls while # denotes p,0.05 compared to
the H2O2-treated group.
doi:10.1371/journal.pone.0042586.t001
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compared to the H2O2-treated cells. Oxidative stress reduced the
levels of anti-apoptotic gene Bcl2. Compared to the untreated
groups, the mRNA expression of Bcl2 decreased by 1.56-fold
(p,0.05) and 1.47-fold (p,0.05) at 12 h and 24 h, respectively,
upon treatment with H2O2 (Figure 3 C). The reduced mRNA
expression of Bcl2 under oxidative stress was reversed by
pretreatment with Tb4 by 1.14-fold (p,0.05) and 1.2-fold
(p,0.05) at 12 h and 24 h, respectively, compared with the
H2O2-treated cells (Figure 3 C).
At the translational level, H2O2 treatment resulted in a 4.7-fold
(p,0.05), and 6.6-fold (p,0.05) increase in the expression of
caspase3 at 12 h and 24 h treatment, respectively compared to the
control. Tb4 pretreatment in the H2O2 stimulated cells resulted in
1.6-fold (p,0.05) and 1.7-fold (p,0.05) decrease in the caspase3
protein expression at 12 h and 24 h treatment, respectively,
compared to the H2O2-treated cells. (Figure 3 D). The normalized
quantification of caspase-3 by western blotting is shown in the
Figure 3 E. The Bax/Bcl2 ratio was also evaluated at protein level
in cardiomyocytes. Our data showed that the Bax/Bcl2 ratio
increased to 2.3-fold (p,0.05) and 3.0-fold (p,0.05) at 12 h and
24 h, respectively, under H2O2 treatment compared to the
controls (Figure 3 D). Tb4 treatment significantly reduced the
increase in Bax/Bcl2 ratio by 1.9-fold (p,0.05) and 2.32-fold
(p,0.05) at 12 h and 24 h, respectively, compared to the H2O2-
treated group (Figure 3 E).
Effect of Tb4 treatment and analysis of NF-kB target
genes by RT2 PCR array
To gain further insight into NF-kB-target genes, we performed q
RT-PCR array. The data showed alteration of NF-kB family genes
in H2O2 treated cardiomyocytes, compared to unstimulated cells.
Furthermore, Tb4 treatment restored those altered genes signif-
icantly. The list of NF-kB genes are shown in Table S1. Our data
showed that H2O2 treatment induced upregulation of several NF-
kB target genes, importantly, the following: TNFa, Irak1, Stat1,
Tgfbr1, IkBa, IKKb, Casp1, Rel, Egr1, NF-kB1, Tgfbr2, Rela,
Ifnc, Ccl2, Fasl, Il1b, IL-6 and Fadd. A list of selected NF-kB
family genes is provided in Table S2.
Figure 2. Effect of Tb4 on anti-oxidative enzymes under oxidative stress in cardiomyocytes. (A) Relative fold change in the mRNA
expression of Mn-SOD, (B) Cu/Zn-SOD and (C) Catalase, in cardiomyocytes treated with H2O2 in presence and absence of Tb4. Data represent the
means 6 SE of at least three separate experiments. (D) Western blots showing the protein expression of Mn-SOD, Cu/Zn-SOD and catalase at 12 h
and 24 h, respectively. GAPDH was used as internal loading control for the experiment. (E) Graph shows the relative fold change in the protein
expression of Mn-SOD, Cu/Zn-SOD and catalase, respectively by densitometry. Data represent means6 SEM from 3 individual experiments. * denotes
p,0.05 compared to controls while # denotes p,0.05 compared to the H2O2-treated group.
doi:10.1371/journal.pone.0042586.g002
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Validation of NF-kB target genes in cardiomyocytes
The expression of NF-kB target genes, FasL, TNFa, c-Fos, c-
Jun and ICAM-1 were analyzed in H2O2 treated cardiomyocytes
in the presence and absence of Tb4. Our data showed that the
expression of FasL, TNFa, c-Fos, c-Jun and ICAM-1 genes were
increased by 1.4560.07, 1.8160.25, 1.1460.03, 1.4260.17and
1.2960.12 fold (p,0.05), respectively, in H2O2 treated cardio-
myocytes, compared to untreated cells. The Tb4 treated showed
significant restoration of the above genes by 1.2260.1, 1.4660.16,
1.0560.06, 1.1860.12 and 1.1660.11fold (p,0.05), compared
H2O2 treated cardiomyocytes (Figure 4).
Tb4 selectively upregulates Cu/Zn-SOD and Bcl2 genes in
cardiac myocytes
We took knock-down approach to further validate the target
molecule of Cu/Zn-SOD and Bcl2 by Tb4. Both genes were
knock- down in cardiomyocytes using their specific siRNAs and,
were subsequently challenged with H2O2 in the presence and
absence of Tb4. The scramble siRNA were used as a control.
Pretreatment with Tb4 in scramble transfection enhanced the
expression of Cu/Zn-SOD and Bcl2 under normal conditions
(Fig. 5 A and 5 C). H2O2 treatment significantly downregulated
the Cu/Zn-SOD and Bcl2 protein to 0.6760.01 and 0.4560.08-
fold (p,0.05), respectively, compared to control. Tb4 pretreat-
ment for 24 h partly restored the expression of both Cu/Zn-SOD
Figure 3. Effect of Tb4 on pro-and anti-apoptotic proteins under oxidative stress in cardiomyocytes. Relative fold change mRNA
expression of (A) Caspase-3, (B) Bax and (C) Bcl2. Data represent the means 6 SE of at least three separate experiments. (D) Protein expression of
Caspase-3, Bax and Bcl2 at 12 h and 24 h, respectively. GAPDH was used as loading control for the experiment. (E) Graph shows the relative fold
change in the protein expression of Bax, Bcl2 and caspase-3, respectively by densitometry. Data represent means 6 SEM from 3 individual
experiments. * denotes p,0.05 compared to controls while # denotes p,0.05 compared to the H2O2-treated group and
@ means p= ns compare to
the H2O2-treated group.
doi:10.1371/journal.pone.0042586.g003
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and Bcl2 to 0.8460.03 and 0.7460.01-fold (p,0.05), respectively,
compared to H2O2 treated cells (Fig. 5 A and 5 C). Furthermore,
the cardiomyocytes challenged with H2O2 in Bcl2 depletion
showed further degradation of Bcl2 protein to 0.2960.03-fold
compared to H2O2 treated cells (p,0.05). Pretreatment partially
recovered Bcl2 protein to 0.4460.03-fold, compared t0 H2O2
treated cells. Likewise, the cardiomyocytes challenged with H2O2
in Cu/Zn-SOD depletion showed further degradation of Cu/Zn-
SOD protein to 0.2760.02-fold (p,0.05), compared to H2O2
treated cells. Pretreatment partially recovered Cu/Zn-SOD
protein to 0.4660.02-fold (p,0.05), compared t0 H2O2 treated
cells. The quantification of western analysis was shown in Fig. 5 B
and 5 D.
We then evaluated the expression of apoptotic marker gene,
caspase-3 under the similar setting. The scramble transfection
showed significant attenuation of caspase3 gene expression in
Tb4treated cells compared to H2O2 treated cells. The expression
of caspase-3 increased to 2.5660.69-fold (p,0.05) in H2O2
treated cell which was reduced by 1.8060.54-fold upon pretreat-
ment with Tb4 (Fig. 5 E, left panel). Our data further showed that
knocking down of both Cu/Zn-SOD and Bcl2 significantly
enhance the caspases3 gene expression even in unstimulated cell.
The expression of caspase3 was increased with the knockdown of
Bcl2 by 2.6561.3-fold in unstimulated cells. H2O2 treatment
resulted in 4.0461.16-fold increase and Tb4 pretreatment showed
2.660.13-fold reduction of caspase3 expression in H2O2 treated
cells (Fig. 5E, middle panel). The caspase3 gene expression was
determined in Cu/Zn-SOD depleted cells. The expression of
caspase3 was increased by 2.3261.1 fold in unstimulated cells
(Fig. 5E, right panel). The expression of caspase3 was further
increased to 4.1961.52 fold (p,0.05) with the knockdown of Cu/
Zn-SOD gene by siRNA transfection. Tb4 pretreatment showed
2.360.70-fold (p,0.05) reduction of caspase3 expression in H2O2
treated cells (Fig. 5E, right panel).
The TUNEL assay, performed under similar experimental
conditions, showed increase in the TUNEL-positive nuclei under
H2O2 treatment and, si-RNA knockdown of Cu/Zn-SOD, and
Bcl2 further increased the TUNEL-positive cells. Representative
fluorescence microscopy images showing TUNEL-positive nuclei
(FITC-positive) of H2O2 treated in presence and absence of Tb4
were shown in Figure 6 A and B. H2O2 treatment resulted in an
increase of TUNEL-positive nuclei from 2.262.2% to
13.3363.84% (p,0.05) in the scrambled si-RNA transfection.
Both Bcl2 and Cu/Zn-SOD depleted cells challenge with H2O2
resulted further increase in the TUNEL-positive nuclei to
28.8962.22% (p,0.05) and 22.2262.622% (p,0.05), respective-
ly (Figure 6 C). Pretreatment with Tb4 in the H2O2 treated group
resulted in a significant reduction in the TUNEL-positive nuclei to
4.462.2% (p,0.05) in scramble transfected cell, 13.363.84%
(p,0.05) in si-RNA- Bcl2 and 11.1162.22% (p,0.05) in si-RNA-
Cu/Zn-SOD transfected cells, respectively (Figure 6 C). These
results indicate that Tb4 selectively targets Bcl2 and Cu/Zn-SOD
genes to provide cardiac protection under oxidative stress.
Discussion
The present study showed for the first time that Tb4 protects
cardiomyocytes under oxidative stress by upregulating antioxidant
enzymes and reducing pro-apoptotic and pro-inflammatory genes.
H2O2 elicits marked increment in intracellular ROS that promotes
degradation of antioxidant enzymes (Cu/Zn-SOD and catalase)
and activates pro-apoptotic (Bax and caspase3) and pro-inflam-
matory genes in cardiomyocytes. Increased ROS further advocate
detrimental changes in cardiomyocytes leading to the loss of
mitochondrial membrane potential and, subsequently increases
the Bax/Bcl2 ratio favoring apoptosis. Pretreatment with Tb4
showed significant attenuation of ROS activity and restoration of
the above molecules and protecting cardiomyocytes from oxidative
stress. Finally, we showed that knocking down of either Cu-Zn-
SOD or Bcl2 in cardiomyocytes failed to protect the cells from
oxidative stress in presence of Tb4.
The myocardium has a complex mechanism to maintain the
oxygen supply demand in response to diverse physiological and
pathological stresses and, control the contractile function. The
major pathological manifestation of oxidative stress is the
generation of ROS that damage the cellular activity and function.
It has become more apparent that the effect of oxidative stress in
cardiac cells predisposes the condition that lead to adverse cardiac
remodeling including cell death, myocardial hypertrophy and
contractile dysfunction [6,35,36]. Cardiomyocytes are the major
‘‘bulk’’ in the myocardium and primarily governs the contractile
function. Any sort of stress will have a serious impact on
cardiomyocytes and affect various signaling cascades that
ultimately lead to dysfunction. In an attempt to protect these cells
under oxidative stress, we tested the efficacy of Tb4 in
cardiomyocytes which is currently undetermined. Our results
indicate that cardiomyocytes pretreated for 2 h with Tb4 increases
the cell viability under oxidative stress suggest that Tb4
contributes a crucial role in the cardio-protection under oxidative
stress.
Oxidative stress and ROS have been implicated in triggering
cell death. Following a one-, two- or three-electron reduction, O2
may generate successively O2
.2 (superoxide radical), H2O2 or
OH2 (hydroxyl radical). ROS are able to oxidize biological
macromolecules such as DNA, protein and lipids [37,38].
Superoxide dismutase (SOD) converts O2
.2 into H2O2 and the
latter can generate OH2 in the presence of Fe2+ cations (Fenton
reaction). It should be noted that nitric oxide (NO) can also be
oxidized into reactive nitric oxide species, which may show
behavior similar to that of ROS. In particular the combination of
NO and O2
.2 can yield a strong biological oxidant, peroxynitrite
that is more detrimental to the cells [10,39]. In our study, we
showed that treatment of Tb4 restored all H2O2 induced free
radical generation in cardiomyocytes suggesting a protective role
in this setting. One of the traditional hallmarks of ROS-initiated
cell death is mitochondrial dysfunction and energy depletion
[40,41]. Several mechanisms can impair energy production in
cardiac mitochondria, including damage to the electron transport
chain and phosphorylation apparatus, mtDNA injury, opening of
Figure 4. Effect of Tb4 on pro-inflammatory molecules under
oxidative stress in cardiomyocytes. Relative fold change in the
mRNA expression of FasL, TNFa, c-Fos, c-Jun and ICAM1. Data represent
the means 6 SE of three separate experiments. * denotes p,0.05
compared to controls. # denotes p,0.05 compared to H2O2 group
with Tb4 treated group.
doi:10.1371/journal.pone.0042586.g004
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the mitochondrial permeability transition pore (MPTP), the loss of
the mitochondrial membrane potential (DYm) and, the concom-
itant drop in ATP production [42,43]. Dysfunction of mitochon-
drial machinery in the heart releases apoptotic signaling molecules
e.g. cytochrome c and may cause an irreversible injury to the
mitochondria [44]. Our data showed significant decrease in DYm
which was prevented by pretreatment with Tb4.
Tb4 is very effective in reducing intracellular ROS in H2O2-
treated cardiomyocytes. Our study is the first to show that the
attenuation of ROS is mediated by restoring Cu/Zn-SOD and
catalase, the two important antioxidant enzymes. Another relevant
antioxidant that loses function upon oxidation is Mn-SOD.
Although, both Mn-SOD and Cu/Zn-SOD have been reported
to play a crucial role in protecting the cardiac cells from oxidative
damage by scavenging ROS [13,45] but, we found that Tb4
upregulated the expression levels of Cu/Zn-SOD in cardiomyo-
cytes. Catalase, which was directly responsible for H2O2 clearance,
was upregulated by Tb4 both at mRNA and protein level in the
presence of H2O2 stimulus indicating that Tb4 preferentially
targets catalase in the cardiomyocytes which enable effecting
scavenging of the H2O2 from the system. Also it was worth notice
that even though the protein and gene expression levels of both
catalase and Cu/Zn-SOD were increased by Tb4, this peptide
upregulated the gene encoding the former more efficiently in
cardiomyocytes. Furthermore, oxidative stress promotes apoptotic
cell death by lowering Bax/Bcl2 ratio. In our study, we showed
that Tb4 reduced the intracellular ROS levels in cardiomyocytes
and prevents cell death by restoring Bax/Bcl2 ratio and inhibiting
the activation of caspase3. This observation supports our previous
observation using cardiac fibroblast [31] but, contrast to the
previous reported by Sosne G et al where they did not observe any
change in Bax/Bcl2 expression [30]. We did not know the reason
for this but, the use of different cell type may accountable for this
altered phenomenon.
To confirm the target of Cu/Zn-SOD and Bcl2 by Tb4 in order
to protect the cardiomyocytes from oxidative stress, we selectively
knocked down these molecules and determined the efficacy of Tb4
under oxidative stress. We found that Tb4 prevented cell death by
specifically targeting Cu/Zn-SOD and Bcl2 molecules in H2O2
treated cardiomyocytes. But, when these molecules were knocked
down in the cell, Tb4 failed to protect the cells from apoptosis.
These data led us to convey the message that Tb4 may provide
Figure 5. Effect of Tb4 treatment after knocking down of Cu/Zn-SOD and Bcl2 in presence and absence H2O2-induced oxidative
stress in cardiomyocytes. (A) Neonatal cardiomyocytes were transfected with scramble and Bcl2 siRNA, (C) scrambled and Cu/Zn-SOD siRNA in the
presence and absence of Tb4 under oxidative stress and Western blotting was performed using Bcl2 and Cu/Zn-SOD antibodies as probe. (B and D)
Representative showing the quantification of panel A and C (E) Bar graph shows relative fold-change in the mRNA expression of caspase-3 in
cardiomyocytes under similar experimental condition stated in A and B. Data represent the means 6 SE of at least three separate experiments.
* denotes p,0.05 compared to controls while # denotes p,0.05 compared to the H2O2-treated group with Tb4 treated group.
doi:10.1371/journal.pone.0042586.g005
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cardiac protection under oxidative stress by restoring Cu-Zn SOD
and Bcl2 levels in the myocardium.
Our study also indicates that Tb4 protects the cardiomyocytes
from oxidative stress by attenuating pro-inflammatory genes
regulated by NF-kB. It is evident that ROS activation often
triggers NF-kB translocation and thereby promotes pro-inflam-
matory response [46,47] As mentioned previously, ROS are toxic
in cells and damage the cellular integrity, it is therefore, critical to
make a balance of ROS production in order to prevent further
oxidative damage. In this setting, our study further indicates that
Tb4 protects the cardiomyocytes from oxidative stress by
attenuating the pro-inflammatory genes regulated by NF-kB.
Taken together, our data validate and re-established a potential
role Tb4 as an anti-inflammatory molecule which may provide a
new therapeutic module for cardiac protections under oxidative
stress. Future studies may aim to delineate the interaction or
association between NF-kB and Tb4 in the context of NF-kB
transcriptional regulatory circuit and anti-inflammatory properties
in the cardiac cells.
In conclusion, we demonstrated that Tb4 protects the
myocardium from oxidative stress by reducing ROS activity via
re-establishing the antioxidant enzyme levels, Cu/Zn-SOD and
catalase and, further attenuating Bax and caspase3 levels and
restoring Bcl2 as well. Our results not only offered more
mechanistic explanation about the protective mechanism of Tb4
but also supported the need to further investigate the use of this
small molecule in protecting the myocardium against oxidative
damage in variety of disease condition where ROS has been
Figure 6. Representative fluorescent microscopy images of TUNEL staining in rat neonatal cardiomyocytes. (A) Bright TUNEL-positive
images from control, H2O2 treated and H2O2 treated but pretreated with Tb4 (upper panel). The lower panel showed the images of corresponding
DAPI stained with a-actinin, a myocyte specific marker protein. (B) Representative fluorescent microscopy images showed the effect of Tb4 treatment
in the presence and absence of H2O2-induced oxidative stress on cardiomyocytes transfected with si-RNA-Bcl2 and siRNA-Cu/Zn-SOD vs. scrambled
siRNA, respectively (C) Bar graph shows the percent TUNEL-positive nuclei under similar experimental condition. Data represent the means6 SE of at
least three separate experiments. A total of 45 to 65 nuclei were counted for each observation. * denotes p,0.05 compared to controls while #
denotes p,0.05 compared to the H2O2-treated group with Tb4 treated group.
doi:10.1371/journal.pone.0042586.g006
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implicated to play a damaging role like cardiac hypertrophy and
heart failure.
Therapeutic implication
Our findings are relevant in the clinical settings as many studies
have shown that depletion of anti-oxidants in the heart makes it
more vulnerable to damage especially under ischemia and under
high pro-oxidant condition. Although, we did not investigate adult
rat cardiomyocytes, but, many studies have shown that primary
cultured neonatal rat cardiomyocytes were useful models to
investigate cardio-protective effects. Future studies are, therefore,
warranted to examine the effect of Tb4 under the similar setting.
We believe that Tb4 is a better therapeutic target as it has the
ability to enhance the expression of the selected antioxidant and
anti-inflammatory genes, thereby, alleviating the damage to the
myocytes under oxidative stress. These possibilities regarding the
mechanisms whereby Tb4 modulates the above molecules need to
be further tested experimentally in future studies.
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